# 人工肺市场

> 人工肺市场研究报告按类型（体外膜氧合、呼吸机支持系统、可植入人工肺）、按应用（呼吸衰竭、肺移植、心脏支持）、按最终用途（医院、居家护理、专科诊所）、按产品配置（便携式系统、固定系统、可穿戴系统）和按地区（北美、欧洲、南美、亚太、中东和非洲） - 增长与行业预测2025至2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 8.18%
- **2024:** $ 1.44 Billion
- **2025:** $ 1.56 Billion
- **2035:** $ 3.43 Billion
- **Key Players:** Medtronic (US), Abbott Laboratories (US), Terumo Corporation (JP), Getinge AB (SE), LivaNova PLC (GB), Fresenius SE & Co. KGaA (DE), Cleveland Heart (US), Xenios AG (DE), Carmat (FR)

**Report ID:** MRFR/LS/36498-HCR · **Pages:** 128 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** October 17, 2026

**URL:** https://www.marketresearchfuture.com/reports/artificial-lung-market-38470

---

## Market Summary

## **Artificial Lung Market Overview**

As per MRFR analysis, the Artificial Lung Market Size was estimated at 1.44 (USD Billion) in 2024. The Artificial Lung Market Industry is expected to grow from 1.56 (USD Billion) in 2025 to 3.17 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 8.18% during the forecast period (2025 - 2034).

**Key Artificial Lung Market Trends Highlighted**

The Global Artificial Lung Market is on the rise, supported mainly by the increasing number of chronic respiratory disease patients, such as Chronic Obstructive Pulmonary Disease and pulmonary fibrosis, as well as their procedures that warrant lung support. There are also newer advancements in lung devices that are changing the functionalities of aided lungs to suit the patients. The presence of better-advanced lung disease care also draws from the need for an aging society that suffers diseases in greater quantities. Advancements aid all these.

The market for artificial lungs has also been boosted by the new designs and materials that have been developed for the lungs. More recently, there has been an increasing emphasis on clinically portable devices that can be utilized in the home environment and not just on hospital grounds. There is a critical need for partnerships between medical device manufacturers, research organizations or institutions, and healthcare providers in order to shorten the time to market and enhance product features.

While the area on the personalization of treatment has been emphasized, opportunities for new lung markets are attracted as the solutions are targeted at patient requirements. As positive outcomes are witnessed in patients and the necessary healthcare awareness spreads across the relevant professionals, the market to which this technology is aimed is steadily increasing.

Pazienti e medici si stanno dimostrando sempre piu’ propensi a impiegare tecniche mini invasive per l’Oxigeno Terapia Meccanica. Al contempo, l’incontro della telemedicina e della considerazione del machine learning nel trattamento respiratorio favoriranno la personalizzazione della terapia sul paziente. A tale evoluzione non solo fa riscontro, investimento in dispositivi assistivi artificiali polmonari, ma anche l’imminente possibilita’ di utilizzo della farmaceutica tradizionale, al fine di ottimizzare i cardiocircolatori.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Artificial Lung Market Drivers**

Increasing Prevalence of Chronic Respiratory Diseases

The increasing prevalence of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis, is a significant driver for the Global Artificial Lung Market Industry. As these conditions become more prevalent due to factors such as smoking, pollution, and an aging population, there is a growing need for effective respiratory support and management solutions. Artificial lungs can play a crucial role in sustaining patients' lives when natural lung function is severely compromised.With projections indicating significant growth in affected populations, the demand for artificial lung devices is expected to rise substantially.

This trend is supported by ongoing advancements in medical technology, enhancing the efficacy and safety of artificial lung devices. Furthermore, healthcare systems are increasingly recognizing the importance of addressing respiratory illnesses promptly to improve patient outcomes and reduce healthcare costs associated with prolonged treatments and hospitalizations.The Global Artificial Lung Market Industry is poised to benefit from this growing awareness and the consequential increase in product adoption, and innovation focused on respiratory support systems.

Technological Advancements in Artificial Lung Devices

Technological advancements in artificial lung devices are a critical driver for the growth of the Global Artificial Lung Market Industry. Innovations in materials, design, and manufacturing processes are leading to the development of more efficient, durable, and user-friendly artificial lungs. Enhanced biocompatibility of materials reduces the risk of complications, while innovations in miniaturization and portability enable easier integration into various healthcare settings.These advancements are instrumental in improving the overall performance of artificial lungs, which increases their adoption by medical facilities and patients alike.

Furthermore, continued investment in research and development is fostering groundbreaking solutions, increasing the appeal of artificial lung technology across the globe.

Government Initiatives and Funding for Respiratory Health

Government initiatives and funding aimed at improving respiratory health drive growth in the Global Artificial Lung Market Industry. Many governments worldwide are recognizing the burden of respiratory diseases on public health and are implementing programs to fund research, improve healthcare infrastructure, and facilitate access to treatment. Such initiatives often include grants for technological innovation in medical devices, including artificial lungs, encouraging the development of cutting-edge solutions.Additionally, these governmental efforts often raise awareness about respiratory health, leading to early diagnosis and increased demand for artificial lung devices as part of comprehensive patient care plans.

**Artificial Lung Market Segment Insights:**

**Artificial Lung Market Type Insights  **

The Global Artificial Lung Market showcases a diverse landscape, classified into various types, notably Extracorporeal Membrane Oxygenation, Ventilator Support Systems, and Implantable Artificial Lungs. In 2023, the market generated a total revenue of 1.23 USD Billion, indicating the growing need for advanced respiratory support systems. The Extracorporeal Membrane Oxygenation (ECMO) segment emerged as a significant contributor, with a value of 0.6 USD Billion in 2023 and projected to grow to 1.2 USD Billion by 2032.

The prominence of ECMO can be attributed to its critical role in providing cardiac and respiratory support for patients suffering from severe respiratory failure, particularly in intensive care settings.Ventilator Support Systems, another key segment, garnered a value of 0.5 USD Billion in 2023, with expectations of reaching 0.9 USD Billion by 2032. The increasing incidence of chronic respiratory diseases and the need for efficient patient management have positioned this segment as a major player in the market.

Furthermore, Implantable Artificial Lungs, although comparatively smaller, valued at 0.13 USD Billion in 2023 and anticipated to rise to 0.4 USD Billion by 2032, are gaining traction due to advancements in biocompatible materials and integrated technologies, offering promising alternatives for long-term respiratory support.The overall market segmentation highlights the rising demand for innovative artificial lung solutions driven by factors such as an aging population, increasing prevalence of respiratory illnesses, and the necessity for efficient emergency and critical care management. However, challenges such as high costs associated with these technologies and the complexity of treatments may impact market growth.

Emerging opportunities lie in technological advancements and the potential for expanding applications of artificial lung systems in both clinical and home settings, paving the way for enhanced patient management solutions.As the Global Artificial Lung Market evolves, the insights from each type segment not only reflect the current landscape but also set a framework for innovative growth pathways in the region and beyond.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Artificial Lung Market Application Insights  **

The Global Artificial Lung Market, valued at 1.23 billion USD in 2023, is experiencing significant growth driven by vital applications in treating various respiratory issues. The market showcases a diverse segmentation that addresses critical needs such as respiratory failure, lung transplantation, and cardiac support. Respiratory failure has become a prominent area, as it necessitates advanced solutions for patients requiring prolonged oxygen support.

Lung transplantation remains a significant application due to the increasing demand for donor organs and the advanced technologies emerging in artificial lung systems.The cardiac support category plays a crucial role, providing essential assistance for patients with severe heart conditions, allowing for improved recovery times and better quality of life. As healthcare technology continues to advance, the Global Artificial Lung Market data shows that these applications are positioned to dominate market growth, driven by increasing patient populations, advancements in medical technologies, and a heightened awareness of treatment options available.

Overall, the Global Artificial Lung Market statistics emphasize how these applications collectively support overall market expansion within this innovative industry.

**Artificial Lung Market End-Use Insights  **

The Global Artificial Lung Market in 2023 was valued at approximately 1.23 billion USD, driven by increasing demand for lung support systems across various end-use settings. Hospitals represent a critical segment in the market, as they are central to managing severe pulmonary diseases and respiratory failure cases, providing necessary advanced care. Home care is also gaining traction, offering more personalized patient management and convenience, which is essential for chronic lung conditions.

Specialized clinics are important as well, addressing unique patient needs and contributing to innovation and access within the market.The Global Artificial Lung Market data reflects a diversification in end-use applications, indicating that the healthcare sector is adapting to a rise in respiratory conditions and an aging population, which in turn fuels market growth. Market trends highlight a shift towards more patient-centric care solutions and technological advancements, but the industry also faces challenges like regulatory hurdles and high costs.

Nevertheless, significant opportunities exist for growth, especially in improving accessibility and affordability in home care settings, where demand is expected to rise steadily in the coming years.The Global Artificial Lung Market statistics exemplify the necessity for targeted strategies to cater to each end-use category effectively.

**Artificial Lung Market Product Configuration Insights  **

The Global Artificial Lung Market, valued at 1.23 billion USD in 2023, showcases a diverse Product Configuration segment that includes Portable Systems, Stationary Systems, and Wearable Systems. The growth of the market is evident, with projections of reaching 2.5 billion USD by 2032, reflecting a strong market orientation towards advanced respiratory solutions. Portable Systems have gained prominence due to their convenience and mobility, catering to patients who require lung support on-the-go.

Stationary Systems continue to dominate the market as they offer robust support for patients with severe respiratory conditions who need constant monitoring and care.Meanwhile, Wearable Systems are emerging as a significant trend, driven by technological innovations that allow for easier integration into daily life, enhancing patient comfort and adherence to treatment. Overall, these configurations are critical in fulfilling the diverse needs of patients optimizing treatment outcomes, and are supported by trends emphasizing personalized healthcare solutions.

The Global Artificial Lung Market data illustrates a clear trend towards these system configurations, indicating a growing acceptance of advanced respiratory management options in clinical settings.

**Artificial Lung Market Regional Insights  **

The Global Artificial Lung Market is experiencing significant growth across various regions, with North America leading the way. It was valued at 0.5 USD Billion in 2023 and is projected to reach 1.02 USD Billion by 2032, indicating its majority holding in overall market revenue. Europe follows with a valuation of 0.3 USD Billion in 2023, expected to grow to 0.64 USD Billion, showcasing its significant role in the market dynamics.

The APAC region is valued at 0.25 USD Billion in 2023 and is projected to reach 0.52 USD Billion, highlighting emerging opportunities in this area.South America and the MEA regions contribute with valuations of 0.1 USD Billion and 0.08 USD Billion in 2023, respectively, reaching 0.22 USD Billion and 0.2 USD Billion by 2032. The challenges in these regions, including regulatory hurdles and market access, are overshadowed by growth drivers such as advancements in technology and an increasing prevalence of respiratory diseases.

The Global Artificial Lung Market segmentation reflects not only geographical expansion but also the growing need for innovative solutions in artificial lung technology, indicating a promising landscape for future investments and developments.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Artificial Lung Market Key Players and Competitive Insights:**

The Global Artificial Lung Market has witnessed significant developments and expansions as healthcare technology continues to advance, and the need for efficient respiratory support increases globally. Competitive insights in this market reveal a landscape where innovation is key, with manufacturers focusing on enhancing product efficacy, safety, and integration capabilities with existing healthcare systems. The interplay of various market dynamics, including regulatory frameworks, technological advancements, and competitive strategies, influences the market's growth trajectory. Companies are engaged in strategic collaborations, research and development, and mergers and acquisitions, aiming to enhance their product portfolios and establish a stronger foothold in the market.

As the market evolves, the emphasis on patient-centric solutions and personalized healthcare continues to rise, prompting firms to develop advanced artificial lung technologies that cater to different patient needs.Abbott Laboratories has established itself as a significant player in the Global Artificial Lung Market. The company is recognized for its robust product development pipeline and commitment to innovation, which is key to staying competitive. Leveraging advanced research and development capabilities, Abbott Laboratories aims to create artificial lung solutions that not only meet market demands but also adhere to the rigorous safety and regulatory standards required in the healthcare sector.

The company's strengths lie in its strong brand recognition, capabilities in optimizing manufacturing processes, and a dedicated focus on addressing specific respiratory challenges faced by patients. This strategic positioning allows Abbott Laboratories to maintain a solid market presence and foster long-term relationships with healthcare providers and institutions focusing on respiratory care.Asahi Kasei Corporation is another prominent entity in the Global Artificial Lung Market, distinguished by its innovative approach and technological prowess in developing artificial lung systems. The company utilizes advanced polymer technology and materials science to design products that offer enhanced performance and biocompatibility.

Asahi Kasei's strengths include its ability to leverage cutting-edge research, ensuring that its artificial lung devices meet evolving healthcare needs and regulatory requirements. This dedication to innovation enables Asahi Kasei Corporation to not only compete effectively within the market but also to establish partnerships with healthcare professionals and research institutions. The company's commitment to providing high-quality and efficient respiratory support solutions further solidifies its position as a leading competitor in this dynamic market.

**Key Companies in the Artificial Lung Market Include:**

**Artificial Lung Market Industry Developments**

The Global Artificial Lung Market has recently witnessed significant developments driven by advancements in medical technology and increasing demand for alternative respiratory solutions. Companies such as Abbott Laboratories and Medtronic are continually innovating to improve the efficiency and safety of artificial lung systems, creating a ripple effect on market growth. Additionally, Asahi Kasei Corporation and Getinge AB are exploring collaborations that aim to enhance product offerings for patients with advanced lung diseases.

The market is also witnessing an uptick in mergers and acquisitions, with LivaNova and Fresenius Medical Care looking to expand their market share, leveraging synergies for improved operational efficiencies and enhanced product portfolios. Furthermore, Nipro Corporation and Baxter International are reportedly investing in R&D to accelerate the development of next-generation artificial lungs, catering to the increasing global healthcare needs. The overall market valuation is expected to rise significantly as stakeholders are keen to capitalize on these innovations and strategic partnerships, reflecting a favorable shift in the competitive landscape.

Overall, the landscape remains dynamic, with strong investor interest and active corporate strategies defining the current state of the artificial lung market.

**Artificial Lung Market Segmentation Insights**

Artificial Lung Market Type Outlook

- Extracorporeal Membrane Oxygenation
- Ventilator Support Systems
- Implantable Artificial Lungs

Artificial Lung Market Application Outlook

- Respiratory Failure
- Lung Transplantation
- Cardiac Support

Artificial Lung Market End-Use Outlook

- Hospitals
- Home Care
- Specialized Clinics

Artificial Lung Market Product Configuration Outlook

- Portable Systems
- Stationary Systems
- Wearable Systems

Artificial Lung Market Regional Outlook

- North America
- Europe
- South America
- Asia-Pacific
- Middle East and Africa

## Market Drivers

### Rising Incidence of Respiratory Diseases

呼吸疾病的流行率正在上升，这是人工肺市场的一个关键驱动因素。慢性阻塞性肺病（COPD）、肺纤维化和其他严重肺部疾病等情况变得越来越普遍，导致对人工肺解决方案的需求增加。根据最近的统计数据，呼吸疾病占全球死亡率的相当大比例，促使医疗系统寻求创新解决方案。这个不断增长的患者群体需要开发和部署人工肺技术，这对于管理严重病例至关重要。随着对有效呼吸解决方案的需求不断上升，人工肺市场有望实现强劲增长，利益相关者专注于研究和开发，以满足这些新兴需求。

### Increased Investment in Healthcare Infrastructure

对医疗基础设施的投资是影响人工肺市场的一个关键因素。政府和私营实体正在将资源投入到改善医疗设施，特别是在呼吸疾病高发地区。这项投资通常包括采购先进的医疗设备，包括人工肺，以改善患者护理。例如，最近的资金倡议已被用于为医院配备最先进的呼吸支持系统。随着医疗系统的发展和扩展，对人工肺技术的需求预计将上升，从而推动市场向前发展。人工肺市场将从这些基础设施改善中受益，因为它们为需要的患者提供了更好的获取生命救助技术的机会。

### Regulatory Support for Innovative Medical Devices

监管机构在塑造人工肺市场方面发挥着至关重要的作用，通过支持创新医疗设备的开发和批准。简化的监管流程和对研究与开发的激励措施鼓励制造商投资于新技术。最近旨在加快生命救助设备批准的倡议可能会改善市场环境。随着监管框架的发展以适应人工肺技术的进步，制造商可能会发现将其产品推向市场变得更加容易。这种支持性环境预计将促进人工肺市场的创新和竞争，最终使需要先进呼吸支持的患者受益。

### Technological Innovations in Artificial Lung Devices

人工肺市场正在经历技术创新的激增，这些创新增强了人工肺设备的功能和效率。最近在生物相容材料和微型化技术方面的进展导致了更有效和用户友好的设备的发展。例如，智能传感器和基于人工智能的算法的集成允许对患者状况进行实时监测，这可能改善结果。预计市场在未来五年内将以约12%的复合年增长率增长，推动这些创新。随着医疗提供者越来越多地采用这些先进技术，人工肺市场可能会经历显著的转变，使呼吸衰竭患者的治疗更加可及和有效。

### Growing Awareness and Education on Respiratory Health

对呼吸健康的认识和教育正在获得关注，这对人工肺市场产生了积极影响。公共卫生运动和教育项目越来越关注肺健康的重要性以及呼吸疾病的可用治疗选择。这种提高的意识可能导致更早的诊断和治疗，从而增加对人工肺设备的需求。医疗专业人员也正在接受培训，以识别严重呼吸疾病的迹象，这可能导致更多患者被推荐进行人工肺干预。随着对呼吸健康理解的扩大，预计人工肺市场将看到相应的人工肺技术采用增加，最终改善患者的治疗效果。

## Future Outlook

预计人工肺市场将在2025至2035年间以8.18%的年均增长率增长，推动因素包括技术进步、呼吸疾病的日益普遍和医疗投资的增加。

**New opportunities:**

- 便携式人工肺设备在家庭护理环境中的开发。

到2035年，人工肺市场预计将实现显著增长，反映出技术进步和需求增加。

## Segment Insights

### 按类型：体外膜氧合（最大）与呼吸机支持系统（增长最快）

人工肺市场主要分为三个关键类别：体外膜氧合（ECMO）、呼吸机支持系统和可植入人工肺。在这些类别中，ECMO占据最大的市场份额，因其在支持严重呼吸和心脏衰竭患者方面的关键作用。呼吸机支持系统因呼吸疾病的日益普遍和对先进呼吸支持技术的需求而成为增长最快的细分市场。可植入人工肺也在获得关注，因为它们代表了长期支持的创新解决方案，但目前相比于ECMO和呼吸机系统占据较小的市场份额。

随着人工肺市场的发展，增长趋势表明对ECMO设备的偏好不断上升，因为它们在急性护理环境中的有效性得到了证明。对呼吸机支持系统的需求正在上升，特别是响应全球健康挑战，突显了对增强患者护理技术的需求。此外，材料和技术的进步正在推动可植入人工肺的创新，尽管监管挑战和高开发成本仍然是障碍。总体而言，市场正在向提供更好患者结果的技术转变，影响制造商在所有细分市场上进行研究和开发的投资。

体外膜氧合（主导）与可植入人工肺（新兴）

体外膜氧合（ECMO）技术已确立为人工肺市场的主导力量，因其在需要临时心肺支持的危急情况下的有效性而广受认可。[ECMO系统](https://www.marketresearchfuture.com/reports/ecmo-system-market-43254)主要在重症监护环境中使用，其提供氧合和循环支持的能力是无价的。相反，尽管可植入人工肺被归类为新兴技术，但它们在市场上代表了一个令人兴奋的前沿，承诺为慢性呼吸疾病患者提供长期支持。虽然ECMO设备提供即时、密集的护理解决方案，但可植入人工肺旨在为慢性问题提供更可持续、以患者为中心的替代方案。随着研究的进展，这两个细分市场可能会相互演变，ECMO为长期人工肺解决方案的进步铺平道路。

### 按应用：呼吸衰竭（最大）与肺移植（增长最快）

在人工肺市场中，呼吸衰竭代表了最大的应用细分市场，占据了市场份额的显著部分。这主要是由于慢性呼吸疾病的高发病率，推动了对帮助氧合血液和提供呼吸支持的人工肺技术的需求。相反，肺移植正在成为增长最快的细分市场，受益于移植技术的进步和需要外科干预的患者数量的增加。

呼吸衰竭：主导与肺移植：新兴

呼吸衰竭细分市场以其在人工肺市场中的确立主导地位而闻名，满足了严重肺功能障碍患者的需求，并提供关键生命支持。该细分市场受益于广泛的临床应用和持续的技术改进。相比之下，肺移植细分市场正在快速崛起，受益于增强器官兼容性和降低排斥率的创新。这些发展与对移植作为终末期肺病可行解决方案的日益认识相结合，从而扩大了其市场存在。

### 按最终用途：医院（最大）与居家护理（增长最快）

人工肺市场主要分为三个关键最终用途类别：医院、居家护理和专科诊所。在这些类别中，医院占据最大的份额，因其强大的基础设施和日益增加的需要先进呼吸支持的患者入院。另一方面，居家护理正在经历显著增长，推动因素是向居家治疗解决方案的转变，特别是随着技术的进步，使得在医院环境外安全有效地管理人工肺设备成为可能。

医院（主导）与居家护理（新兴）

医院在人工肺市场中仍然是主导细分市场，因为它们为严重呼吸疾病患者提供关键护理，并能够使用最先进的医疗技术。医院的需求受到呼吸疾病日益普遍和对即时、密集医疗护理需求的支持。相反，居家护理作为一个重要细分市场正在崛起，推动因素是对以患者为中心的护理模式的日益偏好以及可携带人工肺设备的发展。这一趋势得到了老龄化人口和向远程监测和康复的推动，允许患者在家中舒适地接受护理，同时保持生活质量。

### 按产品配置：便携式系统（最大）与可穿戴系统（增长最快）

在人工肺市场中，产品配置细分市场由便携式系统主导，后者占据最大的市场份额。这些系统因其多功能性和易用性而受到青睐，成为患者和医疗提供者的首选。紧随其后，固定系统提供可靠的性能，通常用于医院环境，而可穿戴系统由于技术的进步和对患者护理中移动性的日益需求而迅速崛起。

随着市场的发展，可穿戴系统被确定为增长最快的细分市场。对以患者为中心的解决方案的日益需求正在推动设计和功能的创新。舒适性增强、体积减小和更好的电池寿命等因素在推动可穿戴系统需求方面至关重要，表明向更具适应性的个人医疗解决方案的转变。

便携式系统（主导）与固定系统（新兴）

便携式系统的特点是其轻便设计，使患者在接受治疗时能够自由移动。这种灵活性使其在居家护理和紧急情况下成为首选，从而在市场中占据主导地位。相比之下，固定系统设计用于临床环境中的固定安装，为危重病患者提供一致和规范的支持。虽然它们提供强大的性能，但其对固定设置的依赖限制了其适应性。市场正在见证一种趋势，即便携式系统的效率可能会影响固定模型的发展，推动它们纳入更多移动功能，以跟上用户期望的步伐。

## Regional Market Share Analysis

### 北美：创新与市场领导

北美是人工肺最大的市场，占全球份额的约45%。该地区受益于先进的医疗基础设施、显著的研发投资以及呼吸疾病的日益普遍。来自FDA等机构的监管支持加速了产品批准，促进了新技术的创新和市场进入。对器官替代疗法的需求不断增加进一步推动了市场增长。
美国在北美市场中处于领先地位，主要参与者如美敦力和雅培实验室主导着市场格局。竞争环境的特点是领先公司之间持续的创新和战略合作。加拿大也为市场做出了贡献，专注于改善医疗服务的可及性和提高患者的治疗效果。成熟公司的存在和新兴初创企业确保了市场环境的动态性。

### 欧洲：监管支持与增长

欧洲是人工肺的第二大市场，占全球份额的约30%。该地区的增长受到对医疗技术的投资增加、老龄化人口上升和支持性监管框架的推动。欧洲药品管理局（EMA）在确保医疗设备的安全性和有效性方面发挥了关键作用，从而增强了消费者信心和市场增长。对呼吸护理创新解决方案的需求也在上升。
欧洲的主要国家包括德国、法国和英国，费森尤斯SE & Co. KGaA和Getinge AB等公司在其中占据重要地位。竞争格局的特点是制造商与医疗服务提供者之间的合作，以增强产品供应。先进研究机构的存在进一步支持了创新，使欧洲成为人工肺市场的关键参与者。

### 亚太地区：快速增长与创新

亚太地区的人工肺市场正在快速增长，占全球份额的约20%。该地区的扩展受到医疗支出增加、慢性呼吸疾病患者数量上升和医疗技术进步的推动。日本和中国等国处于前沿，政府的支持性举措旨在改善医疗基础设施和获取创新治疗。对器官捐赠和移植的认识不断提高也促进了市场增长。
日本是该地区的领先国家，Terumo公司在人工肺技术方面取得了显著进展。中国也正在成为一个关键参与者，专注于本地制造并减少对进口的依赖。竞争格局的特点是成熟企业和初创企业的结合，推动创新并改善患者护理解决方案。

### 中东和非洲：未开发的潜力与挑战

中东和非洲地区在人工肺市场中逐渐崭露头角，目前占全球份额的约5%。增长受到医疗投资增加、呼吸疾病日益普遍和对先进医疗技术的兴趣上升的推动。然而，有限的医疗基础设施和监管障碍等挑战仍然存在。各国政府越来越认识到改善医疗解决方案的必要性，这预计将推动未来的增长。
南非和阿联酋等国在该地区的市场中处于领先地位，努力改善医疗服务的可及性和质量。竞争格局仍在发展中，市场中出现了本地和国际参与者的结合。主要参与者的存在有限，但对合作和合作伙伴关系的兴趣日益增长，以促进创新并改善患者的治疗效果。

## Competitive Benchmarking

全球人工肺市场见证了显著的发展和扩展，因为医疗技术持续进步，全球对高效呼吸支持的需求不断增加。该市场的竞争洞察揭示了一个创新为关键的格局，制造商专注于提高产品的有效性、安全性和与现有医疗系统的整合能力。各种市场动态的相互作用，包括监管框架、技术进步和竞争策略，影响着市场的增长轨迹。公司参与战略合作、研发以及并购，旨在增强其产品组合并在市场上建立更强的立足点。随着市场的发展，对以患者为中心的解决方案和个性化医疗的重视不断上升，促使公司开发满足不同患者需求的先进人工肺技术。雅培实验室已确立其在全球人工肺市场中的重要地位。该公司因其强大的产品开发管道和对创新的承诺而受到认可，这对保持竞争力至关重要。利用先进的研发能力，雅培实验室旨在创造不仅满足市场需求而且符合医疗行业所需的严格安全和监管标准的人工肺解决方案。该公司的优势在于其强大的品牌认知度、优化制造流程的能力以及专注于解决患者面临的特定呼吸挑战。这一战略定位使雅培实验室能够保持稳固的市场存在，并与专注于呼吸护理的医疗服务提供者和机构建立长期关系。旭化成公司是全球人工肺市场的另一家知名企业，以其创新的方法和在开发人工肺系统方面的技术实力而闻名。该公司利用先进的聚合物技术和材料科学设计出提供增强性能和生物相容性的产品。旭化成的优势包括其利用前沿研究的能力，确保其人工肺设备满足不断变化的医疗需求和监管要求。这种对创新的承诺使旭化成公司不仅能够在市场中有效竞争，还能够与医疗专业人士和研究机构建立合作关系。该公司致力于提供高质量和高效的呼吸支持解决方案，进一步巩固了其在这一动态市场中的领先竞争者地位。

## Recent News & Developments

全球人工肺市场最近见证了由医疗技术进步和对替代呼吸解决方案需求增加所驱动的显著发展。雅培实验室和美敦力等公司不断创新，以提高人工肺系统的效率和安全性，从而对市场增长产生连锁反应。此外，旭化成公司和Getinge AB正在探索旨在增强针对晚期肺病患者的产品供应的合作。

市场还见证了并购活动的增加，LivaNova和费森尤斯医疗正在寻求扩大市场份额，利用协同效应提高运营效率和增强产品组合。此外，Nipro公司和百特国际据报道正在投资于研发，以加速下一代人工肺的开发，以满足日益增长的全球医疗需求。整体市场估值预计将显著上升，因为利益相关者热衷于利用这些创新和战略合作，反映出竞争格局的有利变化。

总体而言，市场环境仍然动态，强劲的投资者兴趣和积极的企业战略定义了当前人工肺市场的状态。

## Report Scope

| 市场规模 2024 | 14.43（亿美元） |
| --- | --- |
| 市场规模 2025 | 15.61（亿美元） |
| 市场规模 2035 | 34.28（亿美元） |
| 年均增长率（CAGR） | 8.18%（2025 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 亿美元 |
| 主要公司简介 | 美敦力（美国）、雅培实验室（美国）、Terumo公司（日本）、Getinge AB（瑞典）、LivaNova PLC（英国）、费森尤斯SE & Co. KGaA（德国）、克利夫兰心脏（美国）、Xenios AG（德国）、Carmat（法国） |
| 覆盖的细分市场 | 类型、应用、最终用途、产品配置、地区 |
| 主要市场机会 | 生物相容材料的进步提高了人工肺市场的性能和安全性。 |
| 主要市场动态 | 技术进步和监管变化推动人工肺市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，人工肺市场的预计市场估值是多少？**
A: 人工肺市场的预计市场估值预计到2035年将达到34.28亿美元。

**Q: 2024年人工肺市场的市场估值是多少？**
A: 2024年人工肺市场的市场估值为14.43亿美元。

**Q: 在2025年至2035年的预测期内，人工肺市场的预计年均增长率（CAGR）是多少？**
A: 在2025年至2035年的预测期内，人工肺市场的预计年均增长率（CAGR）为8.18%。

**Q: 哪些公司被认为是人工肺市场的关键参与者？**
A: 人工肺市场的关键参与者包括美敦力、雅培实验室、Terumo公司等。

**Q: 到2035年，人工肺市场的哪个细分市场预计将拥有最高的估值？**
A: 体外膜氧合细分市场预计到2035年将达到13.68亿美元。

**Q: 可植入人工肺市场与呼吸机支持系统相比如何？**
A: 到2035年，可植入人工肺市场预计将达到10.4亿美元，而呼吸机支持系统可能达到10.2亿美元。

**Q: 在人工肺市场中，哪个应用细分市场预计将增长最多？**
A: 呼吸衰竭应用细分市场预计到2035年将增长到9.78亿美元。

**Q: 到2035年，人工肺市场中便携式系统的预计市场规模是多少？**
A: 人工肺市场中便携式系统的预计市场规模预计到2035年将达到9.78亿美元。

**Q: 哪个最终用途细分市场预计在人工肺市场中增长最少？**
A: 家庭护理最终用途细分市场预计增长最少，到2035年将达到1.03亿美元。

**Q: 到2035年，固定系统的市场估值与可穿戴系统相比如何？**
A: 到2035年，固定系统预计将达到11.44亿美元，而可穿戴系统可能仅达到3.06亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/artificial-lung-market-38470*